By Associated Press – Re-Blogged From Newsmax Health
The FDA has approved the first drug designed to prevent chronic migraines. Aimovig is injected monthly just under the skin using a pen-like device and will cost $6,900 per year without insurance.
The Food and Drug Administration’s action clears the monthly shot for sale. Aimovig is the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to win approval by next year, and several pills for preventing migraines are being tested.